NCPA joined the American Pharmacists Association, American Society of Health-System Pharmacists, Healthcare Distribution Alliance, National Association of Boards of Pharmacy, National Association of Chain Drug Stores, National Association of Specialty Pharmacy, and the Retail Industry Leaders Association in signing onto a letter to the Department of Homeland Security opposing a ruling announced by the U.S. Customs and Border Protection (CBP) that would, for the first time, require that country-of-origin marking be included on prescription drug labels that are dispensed by pharmacies and provided directly to patients.
NCPA joined letters in October 2024 and March 2025 to CBP urging it to reconsider its ruling. CBP has not answered our request but has instead recently announced an intention to begin enforcing its requirements. The organizations argue in the current letter that, if implemented, CBP's ruling would interfere with other federal and state statutory and regulatory requirements governing the dispensing of prescription drugs, unduly burden pharmacies, and ultimately place patient safety at risk.
